MENTA CAPITAL LLC - PERNIX THERAPEUTICS HLDGS IN ownership

PERNIX THERAPEUTICS HLDGS IN's ticker is PTX and the CUSIP is 71426V108. A total of 120 filers reported holding PERNIX THERAPEUTICS HLDGS IN in Q1 2015. The put-call ratio across all filers is 3.07 and the average weighting 0.3%.

Quarter-by-quarter ownership
MENTA CAPITAL LLC ownership history of PERNIX THERAPEUTICS HLDGS IN
ValueSharesWeighting
Q2 2016$87,000
-57.6%
195,1360.0%0.01%
-57.1%
Q1 2016$205,000
+26.5%
195,136
+254.8%
0.03%
+33.3%
Q4 2015$162,000
+376.5%
55,000
+414.3%
0.02%
+320.0%
Q3 2015$34,000
-78.8%
10,695
-37.1%
0.01%
-78.3%
Q4 2014$160,000
-22.7%
17,000
-26.4%
0.02%
-39.5%
Q2 2014$207,00023,1000.04%
Other shareholders
PERNIX THERAPEUTICS HLDGS IN shareholders Q1 2015
NameSharesValueWeighting ↓
Sageview Capital 2,223,339$5,603,0001.59%
Orbimed Advisors 2,320,800$5,848,0000.09%
F&C Asset Management plc 1,854,808$4,665,0000.06%
SPHERA FUNDS MANAGEMENT LTD. 56,500$142,0000.04%
Yakira Capital Management, Inc. 11,957$30,0000.03%
Spectrum Management Group, LLC 10,000$25,0000.02%
Weiss Multi-Strategy Advisers LLC 41,152$104,0000.00%
WOLVERINE ASSET MANAGEMENT LLC 30,000$75,0000.00%
PUTNAM INVESTMENTS LLC 129,762$327,0000.00%
Partnervest Advisory Services LLC 220$1,0000.00%
View complete list of PERNIX THERAPEUTICS HLDGS IN shareholders